A detailed history of Granite Investment Partners, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Granite Investment Partners, LLC holds 23,559 shares of GKOS stock, worth $3.5 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
23,559
Previous 28,711 17.94%
Holding current value
$3.5 Million
Previous $3.4 Million 9.66%
% of portfolio
0.14%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$113.62 - $135.39 $585,370 - $697,529
-5,152 Reduced 17.94%
23,559 $3.07 Million
Q2 2024

Aug 12, 2024

SELL
$89.48 - $118.35 $2,147 - $2,840
-24 Reduced 0.08%
28,711 $3.4 Million
Q1 2024

May 13, 2024

SELL
$76.4 - $96.33 $1.12 Million - $1.41 Million
-14,606 Reduced 33.7%
28,735 $2.71 Million
Q4 2023

Feb 14, 2024

SELL
$59.53 - $85.11 $488,741 - $698,753
-8,210 Reduced 15.93%
43,341 $3.45 Million
Q3 2023

Nov 14, 2023

SELL
$69.23 - $79.09 $6,507 - $7,434
-94 Reduced 0.18%
51,551 $3.88 Million
Q2 2023

Aug 07, 2023

SELL
$45.44 - $71.21 $440,222 - $689,882
-9,688 Reduced 15.8%
51,645 $3.68 Million
Q1 2023

May 03, 2023

BUY
$43.88 - $52.48 $79,378 - $94,936
1,809 Added 3.04%
61,333 $3.07 Million
Q4 2022

Feb 10, 2023

BUY
$40.82 - $57.75 $462,857 - $654,827
11,339 Added 23.53%
59,524 $2.6 Million
Q3 2022

Oct 24, 2022

BUY
$46.84 - $58.49 $23,982 - $29,946
512 Added 1.07%
48,185 $2.57 Million
Q2 2022

Jul 22, 2022

SELL
$34.86 - $63.77 $476,466 - $871,608
-13,668 Reduced 22.28%
47,673 $2.17 Million
Q1 2022

May 02, 2022

SELL
$44.33 - $57.82 $760,614 - $992,075
-17,158 Reduced 21.86%
61,341 $3.55 Million
Q4 2021

Feb 10, 2022

BUY
$40.27 - $56.99 $576,626 - $816,039
14,319 Added 22.31%
78,499 $3.49 Million
Q3 2021

Nov 03, 2021

BUY
$47.43 - $84.23 $774,057 - $1.37 Million
16,320 Added 34.1%
64,180 $3.09 Million
Q2 2021

Jul 30, 2021

SELL
$73.06 - $97.7 $607,932 - $812,961
-8,321 Reduced 14.81%
47,860 $4.06 Million
Q1 2021

May 13, 2021

SELL
$70.43 - $97.42 $486,037 - $672,295
-6,901 Reduced 10.94%
56,181 $4.72 Million
Q4 2020

Feb 12, 2021

SELL
$48.9 - $75.26 $127,091 - $195,600
-2,599 Reduced 3.96%
63,082 $4.75 Million
Q3 2020

Nov 06, 2020

BUY
$37.23 - $50.97 $174,720 - $239,202
4,693 Added 7.69%
65,681 $3.25 Million
Q2 2020

Aug 03, 2020

SELL
$28.78 - $46.83 $23,225 - $37,791
-807 Reduced 1.31%
60,988 $2.34 Million
Q1 2020

May 14, 2020

SELL
$25.53 - $70.14 $4.08 Million - $11.2 Million
-159,712 Reduced 72.1%
61,795 $1.91 Million
Q4 2019

Feb 10, 2020

BUY
$54.18 - $65.64 $681,584 - $825,751
12,580 Added 6.02%
221,507 $12.1 Million
Q3 2019

Nov 12, 2019

BUY
$58.58 - $83.91 $603,549 - $864,524
10,303 Added 5.19%
208,927 $13.1 Million
Q2 2019

Aug 07, 2019

SELL
$63.59 - $78.71 $6.04 Million - $7.48 Million
-95,048 Reduced 32.37%
198,624 $15 Million
Q1 2019

May 13, 2019

BUY
$50.75 - $80.54 $2.06 Million - $3.27 Million
40,555 Added 16.02%
293,672 $23 Million
Q4 2018

Feb 13, 2019

SELL
$52.18 - $67.93 $8.73 Million - $11.4 Million
-167,216 Reduced 39.78%
253,117 $14.2 Million
Q3 2018

Nov 08, 2018

BUY
$38.13 - $68.37 $536,412 - $961,829
14,068 Added 3.46%
420,333 $27.3 Million
Q2 2018

Aug 06, 2018

SELL
$27.62 - $44.51 $994,761 - $1.6 Million
-36,016 Reduced 8.14%
406,265 $16.5 Million
Q1 2018

May 04, 2018

BUY
$26.05 - $34.5 $10.3 Million - $13.6 Million
393,906 Added 814.28%
442,281 $13.6 Million
Q4 2017

Feb 01, 2018

BUY
$24.5 - $36.01 $84,868 - $124,738
3,464 Added 7.71%
48,375 $1.24 Million
Q3 2017

Nov 08, 2017

BUY
$31.26 - $42.03 $1.4 Million - $1.89 Million
44,911
44,911 $1.48 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.06B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.